Diabetes Type 1 Clinical Trials
2 recruiting trials for Diabetes Type 1. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Diabetes Type 1 clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by HJN Sverige AB/Neko Health (1), Guy's and St Thomas' NHS Foundation Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes. (behavioral, 1 trial).
Track Diabetes Type 1 trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The MIND Study - Microangiopathy IN Diabetes
This clinical investigation will evaluate two contactless optical devices based on spatial frequency domain and laser speckle technology for quantification of the skin...
Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With...
Up to one in two adults with type 1 diabetes find living with and managing diabetes to be emotionally challenging. This 'emotional side' of diabetes - feeling worried, frustrated,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Diabetes Type 1, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Diabetes Type 1, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diabetes Type 1, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.